ProfileGDS4132 / 203367_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 53% 45% 56% 54% 50% 55% 59% 63% 55% 61% 76% 62% 68% 68% 69% 60% 70% 71% 62% 66% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101143.02553
GSM201543Muscle PCOS pioglitazone 121108.97245
GSM201544Muscle PCOS pioglitazone 161156.95756
GSM201545Muscle PCOS pioglitazone 201155.2254
GSM201829Muscle PCOS pioglitazone 231142.15450
GSM201830Muscle PCOS pioglitazon 251156.75155
GSM201831Muscle PCOS pioglitazone 271166.73159
GSM201832Muscle PCOS pioglitazone 31171.41763
GSM201833Muscle PCOS pioglitazone 41140.73355
GSM201834Muscle PCOS pioglitazone 81168.73661
GSM201835Muscle PCOS after pioglitazone 102240.04376
GSM201836Muscle PCOS after pioglitazone 122168.24262
GSM201837Muscle PCOS after pioglitazone 162184.41868
GSM201838Muscle PCOS after pioglitazone 202195.28168
GSM201839Muscle PCOS after pioglitazone 232203.08969
GSM201840Muscle PCOS after pioglitazone 252164.53760
GSM201841Muscle PCOS after pioglitazone 272194.60470
GSM201842Muscle PCOS after pioglitazone 32190.68171
GSM201843Muscle PCOS after pioglitazone 42169.33962
GSM201844Muscle PCOS after pioglitazone 82194.56866